Vasculitis
- Similar Impairments to HRQOL Seen in Patients With ANCA-Associated Vasculitides and RA
- Age at Disease Onset Associated With Type of Clinical Manifestations in Patients With GCA
- Statins May Be Protective Against Vascular Inflammation in Patients With PMR, GCA
- Increased Prevalence of ANCA-Associated Vasculitis Reported
- Rituximab and Cyclophosphamide Remission Induction Have Similar Kidney Failure, Mortality Risk in AAV
- Rituximab Superior to Azathioprine in Prevention of Relapse in ANCA-Associated Vasculitis
- Prevalence of Osteonecrosis in ANCA-Associated Vasculitis Quantified
- Predictive Markers of CMV Viremia in ANCA-Associated Vasculitis Identified
- Cocaine-Induced Granulomatosis With Polyangiitis Described
- Cyclophosphamide Plus Rituximab May Lower ANCA-Associated Vasculitis Relapse Risk
- Overdiagnosis of Behçet Syndrome May Result From Broad Classification Criteria
- Induction Therapy Failure in Granulomatosis With Polyangiitis Linked to Disease Characteristics
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
